5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
Hypomethylating drugs are useful in the management of Myelodysplastic syndromes, but there are only few reports on chronic myelomonocycitic (CMML) leukemia patients. We describe our experience in 3 CMML patients treated with azacitidine. Two patients obtained partial response after 4 treatment cycl...
Saved in:
| Main Authors: | Mariangela Greco, Marianna Criscuolo, Luana Fianchi, Livio Pagano, Maria Teresa Voso |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2011-03-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/317 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Marianna Criscuolo, et al.
Published: (2011-01-01) -
Diagnostic and taxonomic challenges in chronic myelomonocytic leukemia with lymph node involvement: A case report and mini-review
by: Bhaumik Shah, et al.
Published: (2025-01-01) -
Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report
by: Grace S. Park, et al.
Published: (2025-01-01) -
Exogenous Methylation Inhibitor 5‐Azacytidine Accelerates Postharvest Leaf Senescence in Pak Choi by Modulating Transcriptomic and Metabolomic Profiles
by: Dan Wang, et al.
Published: (2025-03-01) -
5‐azacytidine inhibits nonsense‐mediated decay in a MYC‐dependent fashion
by: Madhuri Bhuvanagiri, et al.
Published: (2014-10-01)